Your browser doesn't support javascript.
loading
Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma.
Kiang, Juliann G; Zhai, Min; Liao, Pei-Jun; Ho, Connie; Gorbunov, Nikolai V; Elliott, Thomas B.
Afiliação
  • Kiang JG; Radiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
  • Zhai M; Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Liao PJ; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Ho C; Radiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
  • Gorbunov NV; Radiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
  • Elliott TB; Radiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
Mediators Inflamm ; 2017: 7582079, 2017.
Article em En | MEDLINE | ID: mdl-28408792

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões por Radiação / Receptores de Trombopoetina / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lesões por Radiação / Receptores de Trombopoetina / Anticorpos Monoclonais Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article